Ipilimumab vs Omeprazole
Ipilimumab vs Omeprazole: Overview
This comparison examines the pharmacological differences between Ipilimumab and Omeprazole.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Omeprazole: Proton pump inhibitor that irreversibly blocks H+/K+-ATPase.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Omeprazole β 0.5-1 hour.
Chemical Properties
Molecular Formula: Omeprazole β C17H19N3O3S.
Molecular Weight: Omeprazole β 345.4170 g/mol.
Type: Ipilimumab β Antibody; Omeprazole β Small molecule.